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Abstract
Background: Obtaining membrane proteins in sufficient quantity for biophysical study and biotechnological
applications has been a difficult task. Use of the maltose binding protein/hexahistidine dual tag system with E.coli
as an expression host is emerging as a high throughput method to enhance membrane protein yield, solubility,
and purity, but fails to be effective for certain proteins. Optimizing the variables in this system to fine-tune for
efficiency can ultimately be a daunting task. To identify factors critical to success in this expression system, we
have selected to study U24, a novel membrane protein from Human Herpesvirus type-6 with potent
immunosuppressive ability and a possible role in the pathogenesis of the disease multiple sclerosis.
Results: We expressed full-length U24 as a C-terminal fusion to a maltose binding protein/hexahistidine tag and
examined the effects of temperature, growth medium type, cell strain type, oxidizing vs. reducing conditions and
periplasmic vs. cytoplasmic expression location. Temperature appeared to have the greatest effect on yield; at 37°C
full-length protein was either poorly expressed (periplasm) or degraded (cytoplasm) whereas at 18°C, expression
was improved especially in the periplasm of C41(DE3) cells and in the cytoplasm of oxidizing Δtrx/Δgor mutant
strains, Origami 2 and SHuffle. Expression of the fusion protein in these strains were estimated to be 3.2, 5.3 and
4.3 times greater, respectively, compared to commonly-used BL21(DE3) cells. We found that U24 is isolated with an
intramolecular disulfide bond under these conditions, and we probed whether this disulfide bond was critical to
high yield expression of full-length protein. Expression analysis of a C21SC37S cysteine-free mutant U24
demonstrated that this disulfide was not critical for full-length protein expression, but it is more likely that strained
metabolic conditions favour factors which promote protein expression. This hypothesis is supported by the fact
that use of minimal media could enhance protein production compared to nutrient-rich LB media.
Conclusions: We have found optimal conditions for heterologous expression of U24 from Human Herpesvirus
type-6 in E.coli and have demonstrated that milligram quantities of pure protein can be obtained. Strained
metabolic conditions such as low temperature, minimal media and an oxidizing environment appeared essential
for high-level, full-length protein production and this information may be useful for expressing other membrane
proteins of interest.
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Background
U24, a membrane glycoprotein from Human Herpes-
virus Type-6A (HHV-6A), has garnered recent interest
because a N-terminal fragment of the protein was
shown by Tejada-Simon et al. to activate T-cells [1],
and cause them to cross-react with myelin basic protein,
an autoantigen targeted in the pathogenesis of multiple
sclerosis (MS). Sullivan et al. showed that in vivo
expression of U24 alone could downregulate CD3 T-cell
receptor and transferrin receptor cell-surface expression,
and impair T-cell activation [2,3]. We have previously
demonstrated U24 as an in vitro kinase target for ERK2
MAP kinase, further implicating a potential role for U24
in immune-modulating activity [1,4,5]. Using the
TMMH Server Version 2 [6], open reading frame analy-
sis for U24 from HHV-6A (Strain U1102) predicts
expression of an 87 amino acid, 10 kDa glycoprotein,
identified to have a single transmembrane pass (residues
57-79). U24 also has two cysteines (Cys21 and Cys37),
whose oxidation state is unknown.
Structure/function studies of membrane proteins of
biological interest such as U24 has historically been a
difficult task, primarily because of the limited amount
of material available [7]. Proteins extracted from
natural sources can also have a backdrop of post-trans-
lational modifications such as glycosylation, phosphor-
ylation, etc., thereby precluding any meaningful
structural study of the heterogeneous pool of protein.
It was demonstrated that U24 appeared to have exten-
sive post-translational modifications if expressed in
human cells, consistently giving molecular weights of
20 and 23 kDa by SDS-PAGE [3], which is more than
double the mass predicted by the primary sequence.
Heterologous expression of U24 in a prokaryotic
system such as E. coli can therefore represent a cost-
effective and relatively easy way to obtain large yields
of homogeneous membrane proteins where post-trans-
lational modifications can be added subsequently in a
controlled manner.
Protein fusion tags have a direct bearing on expression
levels, solubility and/or efficiency of purification. Typical
fusion tags used include glutathione-S-transferase (GST)
[8], maltose binding protein (MBP) [9] and hexahistidine
(6 × His) tags [10], amongst many others. Since no sin-
gle bacterial strain or fusion tag has been shown to
work in all cases for membrane proteins, the trial-and-
error task of discovering which selection will work to
produce enough pure protein for study can be quite
daunting [11]. In a high-throughput screening sense, an
approximate yield of 0.5 mg of purified membrane pro-
tein per L of E.coli culture has been considered the
acceptable lower expression limit for cost-effective scale
up with the intent on performing structural studies [12].
A yield of 3-5 mg of purified membrane protein per L
of culture is deemed to be a high level [13].
Combining the solubility-enhancing chaperone ability
of MBP [9,14] with the high affinity of a polyhistidine
tag (≥ 6 consecutive histidines) for efficient protein
expression and purification is not a recent development
[15], but has seen a recent revival in the context of
high-throughput protein production [16]. Even so, the
combinatorial use of MBP and 6 × His tags is only
beginning to be extensively explored with membrane
proteins. For instance, Korepanova et al. demonstrated
that this system could enable a 70% success rate in
expressing 16 of 22 integral membrane proteins from
Mycobacterium tuberculosis in the cytoplasm of E. coli,
proteins which would otherwise be unobtainable due to
poor or undetectable expression levels [17].
An added benefit of using MBP as a fusion tag is that
one can generally choose the location within the E. coli
where the expressed protein resides: either in the cyto-
plasm or periplasm [16]. MBP contains a signal sequence
and thus naturally resides in the periplasm of E. coli, yet if
the signal sequence is deleted, MBP remains in the cyto-
plasm. While the most common approach is to express
fusion proteins in the cytoplasm [16], because the yield is
generally higher than those expressed in the periplasm,
there may still be valid reasons why the expression of a
protein of interest should be directed to the periplasm. For
instance, the guinea pig sigma-1 receptor, when engi-
neered as a fusion to the MBP-6 × His dual tag, could
only be expressed as a periplasmic-directed fusion protein
[18]. In this case, it was hypothesized that the receptor
portion becomes stably embedded in the E. coli membrane
as a result of the periplasmic transport process. This
hypothesis is consistent with what was observed for the
expression of the aquaporin Z membrane protein as a
periplasmic MBP fusion, where 200 mg/L of protein were
obtained, but was not found to be secreted out into the
periplasmic space [19].
If there are cysteines in the primary sequence of a
protein and their oxidation state is unknown, as is the
case with U24, it can be beneficial to express the protein
in the oxidizing environment of the periplasm [20] or
use an oxidizing strain of E.coli [21]. It is generally
accepted that disulfide bonds cannot be formed in the
cytoplasm of E. coli unless strains such as Origami
(Novagen), which are defective in reductases ((Δtrx/
Δgor) are used. More recently however, it was shown
that disruption of reducing pathways in E.coli was not
absolutely essential to obtain disulfide-bonded proteins
in the cytoplasm. Introduction of the sulfhydryl oxidase
Erv1p into a native reducing cytoplasm was used to
achieve greater yields of a disulfide-bonded protein than
with reductase-deficient strains alone [22,23].
Tait and Straus Microbial Cell Factories 2011, 10:51
http://www.microbialcellfactories.com/content/10/1/51
Page 2 of 12
Interestingly, MBP may help promote correct
disulfide bond formation in fused proteins. Planson et
al. [24] showed that the C-terminal fragment of Plas-
modium falciparum merozoite surface protein 1 was
misfolded and formed disulfide linked polymers when
expressed untagged in the periplasm, but was a cor-
rectly folded monomer with six intramolecular disul-
fides when expressed fused to MBP. This result clearly
demonstrates the potential that MBP has for introdu-
cing correct disulfide bonding into globular proteins, a
property which would be important in membrane pro-
teins as well.
In this study, we demonstrate how using a fusion to a
maltose binding protein/hexahistidine tag can be benefi-
cial for the expression of good quantities of pure U24.
This work also examines the effects of temperature,
growth medium type, cell strain type, oxidizing vs. redu-
cing conditions and periplasmic vs. cytoplasmic expres-
sion location on expression yields.
Results
Cloning and Expression
Oligonucleotide fragments representing the U24 gene
were synthesized and the full-length gene was obtained
by overlap PCR, before being cloned into two expression
vectors: pMAL-c2x, pMAL-p2x (New England Biolabs)
(Figure 1). Vectors pMAL-c2x and pMAL-p2x direct the
MBP-6 × His-U24 fusion protein to the E. coli cyto-
plasm and periplasm, respectively. The commercially
available E. coli cell strains that were chosen for expres-
sion were XL1-Blue (Stratagene), BL21(DE3) (Strata-
gene), C41(DE3) (Lucigen), Origami 2 (Novagen), and
SHuffle (New England Biolabs). The C41(DE3) strain
[25] is a derivative of the commonly used BL21(DE3)
strain which allows high expression yields of membrane
proteins by reducing their toxicity to the host [11].
Origami 2 is deficient in the glutathione and thioredoxin
reductases (Δtrx/Δgor) and therefore provides an oxidiz-
ing environment conducive to disulfide formation. SHuf-
fle is deficient in the same reductases, but expresses a
signal-truncated disulfide bond isomerase (DsbC) in the
cytoplasm. Normally found in the periplasm, DsbC rear-
ranges incorrect disulfide bonds [26] and can also act as
a chaperone to assist in the proper folding of proteins
that do not require disulfide bonds [20].
Our attempts to express MBP-6 × His-U24 in the
cytoplasm of various cell lines at 37°C yielded a protein
that was truncated (Figure 2C&Figure 2D, indicated by
lower arrow). This truncated product could be easily
purified by Ni2+ affinity and gave a mass of ~45 kDa by
MALDI-TOF MS (data not shown), suggesting that this
isolated form is the MBP-6 × His tag with most of the
U24 portion absent. Of the numerous parameters we
tested, lowering the induction temperature to 18°C
appeared to have the greatest effect on alleviating the
problem of protein truncation, yet the expression of
full-length protein was still somewhat poor in the cyto-
plasm of XL1-Blue, BL21(DE3) and C41(DE3) strains
(Figure 2A&Figure 2B, indicated by arrow). When
expression of MBP-6 × His-U24 was directed to the
periplasm, low levels of full-length protein could be
observed at either 18°C or 37°C, but a substantial
increase in yield of the full-length protein was observed
for C41(DE3), especially over either the XL1 Blue or
BL21(DE3) strains. Densitometric analysis suggest that
periplasmic MBP-6 × His-U24 expression in C41(DE3)
at 18°C is 3.2 × greater than in BL21(DE3) when
expressed under identical conditions (Figure 2E). An
interesting yet unexplained phenomenon is that cyto-
plasmic expression of MBP-6 × His-U24 in C41(DE3) is
actually 3 × less than BL21(DE3) at 18°C. It is unclear
why C41(DE3) should fare any better (or worse) than its
parent strain BL21(DE3), since C41(DE3) is presumed
Figure 1 U24 codon-optimized gene, amino acid sequence and
graphical representation of expressed protein construct. A)
BamHI/HindIII cut sites are indicated and used to clone the PCR-
amplified duplex DNA into the corresponding sites of pMAL-p2x
and pMAL-c2x vectors, from which the MBP-6 × His-U24 fusion
protein is expressed. The U24 gene was designed to be preceded
by a hexahistidine tag (6 × His) and LVPRGS thrombin cleavage site
(indicated by an arrow). Final thrombin-cleaved and purified U24
protein will include an additional two amino acids (Gly-Ser) at the
N-terminus. B) Cartoon representation of expressed protein. The
difference in constructs is a signal sequence at the N-terminus of
the protein expressed by pMAL-p2x-U24, directing expression to the
periplasm. The Factor Xa cleavage site is vector-encoded.
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to only enhance protein production from a T7-based
promoter [11]; here a Ptac promoter was used. We were
prompted to question whether it was specifically an oxi-
dizing environment like the periplasm that had a posi-
tive effect on expression levels. When MBP-6 × His-U24
was expressed in the oxidizing cytoplasm of Origami 2
and SHuffle, higher expression was observed in these
strains over the reducing cytoplasm of the other strains
tested. Densitometry revealed that MBP-6 × His-U24
expression is an estimated 5.3 × higher in Origami 2
and 4.3 × higher in SHuffle compared to BL21(DE3)
(Figure 2E). Low temperature was still critical for the
generation of full-length protein. The presence of DsbC
in the SHuffle strain did not enhance the apparent pro-
tein yield over Origami 2 cells. Since MBP has no
cysteines, these findings suggested that the oxidation
state of the cysteines in U24 may have an effect on
expression levels. The chaperone-like qualities of the
MBP moiety may help protect the U24 passenger pro-
tein against proteolysis under oxidative conditions and
low temperature, enabling optimal conditions for folding
and possible disulfide-formation. An alternative factor
Figure 2 Comparison of MBP-6 × His-U24 expression in various E. coli strains, at low (18°C) and high temperature (37°C*). Cultures
induced at 18°C (A&B) and 37°C* (C&D) and visualized with His-tag-specific Invision stain (A&C) and Coomassie Blue stain (B&D). Cytoplasmic and
periplasmic expressions are denoted by c and p, respectively. While at high temperature (C&D) MBP-6 × His-U24 appears degraded (c lanes) or
poorly expressed (p lanes), optimal expression conditions are observed at low temperature especially in the periplasm of C41 (DE3), and
cytoplasm of Origami 2 and SHuffle. (*)SHuffle was grown at 30°C, as per vendor’s recommendations, perhaps explaining why at this lower
temperature some trace full length MBP-6 × His-U24 is observed. Position of full-length MBP-6 × His-U24 (right of the marker lane) is denoted
by arrows in A&B, upper arrow in C&D (lower arrows point to truncated/degraded protein). Summary of fold-enhancement for full-length MBP-6
× His-U24 expression at 18°C in the various strains/vectors is listed in E), based on densitometric analysis of bands represented A&B, and
normalized against corresponding BL21(DE3) cytoplasmic/periplasmic expression.
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for increased yields is that degrading proteases are either
inactive or absent under the oxidizing, low-temperature
expression conditions that were tested.
Purification and Isolation of U24
MBP-6 × His-U24 expressed in the C41(DE3) periplasm,
Origami 2 and SHuffle cytoplasm at low temperature were
extracted in soluble form and purified by Ni2+-affinity
(Histrap) chromatography. After digestion by thrombin,
U24 was liberated from MBP-6 × His and further purified
to homogeneity by applying the digest mixture to tandem
Histrap and Q-sepharose columns, and collecting U24 in
the flowthrough. U24 protein that had been purified from
the three E. coli strains ran as a monomer under both
reducing and non-reducing conditions, indicating that
U24 does not form significant amounts of disulfide-linked
polymers (Figure 3), although some trace amounts of what
is presumed to be a U24 dimer was observed under some
conditions. The dimer disappears upon addition of redu-
cing agent. Since our recombinant form of U24 runs at
~10 kDa by SDS-PAGE, we conclude that we have avoided
the unknown post-translational modifications which cause
U24 to run as a doublet of 20 and 23 kDa when expressed
from human cells. Highest yields of U24 (Table 1) were
from C41(DE3) grown in M9 minimal media. Pryor et al.
[15] suggested that use of minimal media reduces the
levels of endogenous E.coli proteases which cleave the sen-
sitive region between the MBP-6 × His tag and protein of
interest.
Secondary Structure Analysis of Purified U24 by CD
Spectroscopy
In order to determine whether the strains used have an
impact on secondary structure of the purified protein,
we determined the structure of the purified U24
obtained above in the presence of membrane-mimetic
SDS detergent, observed by circular dichroism (CD)
(Figure 4). U24 was found to be highly a-helical under
all conditions tested (Table 2). The relative proportions
of secondary structure components (a-helix. b-sheet,
etc.), as determined by fitting the spectra in Figure 5
using the programs CONTILL, SELCON3, and CDSSTR
[27], remain highly similar in the presence and absence
of TCEP reducing agent.
Disulfide Analysis
MALDI-TOF MS was used to analyze purified U24
obtained from the three E.coli strains representing the
highest overexpressed proteins levels, confirming that
U24 existed in a monomeric form of expected mole-
cular mass (experimental = 10,235 ± 0.2% [4]). When
the cysteine modifying reageant N-ethyl maleimide
(NEM) was added alone, no increase in mass was
observed. NEM cannot directly react with disulfide-
bonded cysteines. If a reducing agent is added such as
tris(2-carboxyethyl)phosphine (TCEP), the cysteine
disulfide in U24 is broken, and then the mass shift
attributed to both cysteine thiols being modified by
NEM could be observed (+250 m/z) (Figure 5A&Fig-
ure 5C). These results are the same for U24 samples
obtained from all strains tested. To further confirm
the presence of the disulfide between Cys21-Cys37, a
sample of U24 from SHuffle was subjected to GluC
protease digestion in the presence and absence of
reducing agents, and the resulting peptide fragments
were analyzed by MALDI-TOF MS and SDS-PAGE
(Figure 5B & Figure 5C).
Analysis of Cys-free U24 to Determine the Effects of the
Disulfide on Protein Expression
After confirming that our recombinant U24 forms an
intramolecular disulfide bond, another objective was to
see if formation of this bond directly contributed to the
stability of the expressed full-length MBP-6 × His-U24.
When Cys-free C21SC37S mutant U24 plasmids were
expressed under ideal periplasmic and cytoplasmic con-
ditions (pMAL-p2x-U24 in C41(DE3) and pMAL-c2x-
U24 in Origami 2) in LB media, we observed a similar
trend in expression as compared to wild-type by SDS-
PAGE (Figure 6 and 2A). Removal of the disulfide bond
had no apparent effect on the ability to produce full-
length MBP-6 × His-U24, neither promoting degrada-
tion at low-temperature nor enhancing yield of full-
length at high temperature.
Figure 3 SDS-PAGE analysis of U24 purified from C41(DE3),
Origami 2 and SHuffle E.coli, in the presence and absence of b-
mercaptoethanol reducing agent. Isolated U24 was from
indicated strains, cultured in LB media. Protein solution was mixed
1:1 (vol:vol) with 2X SDS-PAGE buffer ± 2.5% b-mercaptoethanol
(bME) final concentration, and analysis carried out by Tris-Tricine
SDS-PAGE. Protein amounts were approximately as follows: U24C41
(DE3) , 0.1 μg; U24Origami2 and U24SHuffle, 0.4 μg. M: molecular
markers. Arrow points to location of monomeric U24 (10.2 kDa); *
indicates U24 dimer.
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Comparison of Cellular Mass Yields
We observed a trend in the amount of protein-expres-
sing cells from large scale preparations of U24, where
pMAL-p2x-U24 is expressed in C41(DE3) and pMAL-
c2x-U24 in Origami 2 (Figure 7). Despite C41(DE3)
being grown in nutrient-limiting M9 media, these cells
regularly accumulated to a much higher final mass than
Origami 2, which were grown in nutrient-rich LB
media. In our hands, Origami 2 cells expressing MBP-6
× His-U24 grew so slowly in M9 media that further
attempts with this combination were not attempted
(data not shown). It is clear that Origami 2 cells experi-
ence extreme metabolic stress compared to other strains
like C41(DE3). However, with high yields of U24 protein
isolated Origami 2 (Table 1) with low background of
other endogenous E.coli proteins (Figure 2A&Figure 2B),
we hypothesize that the unique metabolism of oxidizing
strains like Origami 2 may favor production of recombi-
nant protein while minimizing expression of proteases
and other factors which lower the expression of full-
length protein.
Discussion
In the course of expressing and isolating U24, we have
shown that membrane protein expression levels can
increase when the E.coli periplasm or an oxidizing cyto-
plasm is used in conjunction with the MBP-6 × His
dual tag, and that highly pure, soluble membrane pro-
tein can be readily obtained in good yields (2-3 mg U24
protein per L of culture, see Table 1). Using this as a
model system, we conclude that use of the MBP-6 × His
tag, together with low temperature, and either the peri-
plasm of C41(DE3) or oxidizing cytoplasm of strains
(Origami 2, SHuffle, etc.) is a worthwhile approach for
obtaining other difficult-to-express membrane proteins
in E. coli. Based on these results, one might expect a
several-fold expression level increase over the com-
monly-used BL21(DE3) cell strain when employing
these conditions to certain other membrane protein sys-
tems. In the current work, we have also determined that
disulfide bonding of the target protein need not be a





C41(DE3) E.coli isolated U24
(mg/L)







MBP-6 × His-U24 Cytoplasm N/A 1.84 ± 0.31 1.60 ± 0.24
pMAL-
p2x
MBP-6 × His-U24 Periplasm 0.46 ± 0.27
2.81 ± 0.32 (M9)
N/A N/A
Results are based on the intensity of expected bands observed by SDS-PAGE and by the BCA assay. U24 was purified as described from the indicated strains
grown in 4 × 1 L of LB (or M9), induced at 18°C. N/A: Not applicable. Concentration is the mean ± s.d. of n = 4-6 independent assay measurements.
Figure 4 Far-UV CD spectra of U24 obtained from the different
cell strains used in this study. U24 protein that had been isolated
from various E. coli cell strains was reconstituted in 10 mM Tris·HCl,
10 mM NaCl, 10 mM SDS, pH 7.5 and far-UV CD was run in the
presence and absence of tris(2-carboxyethyl)phosphine (TCEP)
reducing agent. Concentration of protein in the samples were
determined by BCA assay to be [U24]C41(DE3) = 0.106 ± 0.004 mg/ml,
[U24]Origami = 0.093 ± 0.006 mg/ml, and [U24]SHuffle = 0.118 ± 0.004
mg/ml, where the standard deviation is based on four independent
assay measurements.
Table 2 Secondary Structure Analysis of Purified U24 by
CD Spectroscopy
U24 samplea Secondary Structure Fractionb NRMSDc
aR aD bR bD T U
C41(DE3) 0.412 0.208 0.006 0.032 0.113 0.234 0.150
C41(DE3) + TCEP 0.367 0.212 0.018 0.035 0.127 0.243 0.143
Origami 0.379 0.223 0.023 0.032 0.120 0.222 0.130
Origami + TCEP 0.341 0.201 0.021 0.041 0.134 0.256 0.130
SHuffle 0.411 0.204 0.003 0.03 0.117 0.231 0.156
SHuffle + TCEP 0.401 0.212 0.013 0.032 0.112 0.239 0.147
aU24 protein that had been isolated from various E.coli cell strains was
reconstituted in 10 mM Tris·HCl, 10 mM NaCl, 10 mM SDS, pH 7.5 and far-UV
CD was run (260-195 nm) in the presence and absence of tris(2-carboxyethyl)
phosphine (TCEP) reducing agent.
bFractions of secondary structure were determined by combining the software
analysis results of the CONTIN/LL, SELCON3 and CDSSTR programs [27] using
the SMP56 reference data set. Structural classes are given as: aR, regular a-
helix; aD, distorted a-helix; bR, regular b-strand; bD, distorted b-strand; T, turns;
U, unordered.
cNormalized Root-Mean-Square Deviation. NRMSD is defined as Σ[(θexp - θcal)
2/
(θexp)
2]1/2, summed over all wavelengths, and where θexp and θcal are,
respectively, the experimental ellipticities and ellipticities of the back-calculated
spectra for the derived structure [27,35]. It has been suggested [36] that
experimental and calculated spectra are in good agreement if NRMSD < 0.1, are
similar if 0.1 < NMRSD < 0.2, and are in poor agreement if NRMSD > 0.2.
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Figure 5 Characterization of the disulfide in isolated U24 protein. A) Illustration of isolated U24 protein, demonstrating the formation of a
single intramolecular disulfide bond between the only two cysteines in the molecule (i). N-ethylmaleimide (NEM) does not react with the
oxidized, disulfide bonded protein (ii) and NEM only modifies cysteines in the reduced form (+125 Da per cysteine) once they are reduced by
tris(2-carboxyethyl)phosphine (TCEP) (iii). Use of glutamyl endoproteinase (GluC), which cleaves peptide bonds primarily after glutamic acid under
these conditions, yielded two fragments if U24 contained an intramolecular disulfide (iv). Using dithiothreitol (DTT) to reduce the disulfide in U24
(v), GluC cleavage then gave three proteolytic fragments for U24 (vi). B) Tris-Tricine SDS-PAGE results of U24 (isolated from SHuffle) ± DTT and
GluC-digested. M: molecular markers; oxidized U24 ((i), 10.2 kDa) shifts to a lower mass once cleaved ((iv), 8.6 kDa) and U24 reduced by DTT ((v),
10.2 kDa) shifts to even lower mass when cleaved ((vi), 6.1 kDa). C) MALDI TOF MS analysis of U24 modified with NEM ± TCEP, and cleaved by
GluC ± DTT. Tabulated theoretical masses represent U24 species indicated in A) (i-vi). Experimental masses that were detected are ± 0.2% the
theoretical mass.
Tait and Straus Microbial Cell Factories 2011, 10:51
http://www.microbialcellfactories.com/content/10/1/51
Page 7 of 12
prerequisite for full-length expression of U24. Ulti-
mately, we utilize the C41(DE3) in M9 media regime to
produce isotopically labeled U24 protein for NMR
experiments, while reserving the Origami 2 in LB
approach to routinely produce unlabeled U24 for all
other biophysical studies.
While we are capable of forming (and reducing) a
disulfide in our recombinant version of U24 from
HHV-6A we must consider the fact that the cysteines
are not conserved across the U24 proteins from other
viruses, HHV-6B and HHV-7. All three versions of
U24 have the ability to sequester cellular receptors in
early and intermediate endosomes of human cells [3],
yet while U24HHV-6A has two cytoplasmic cysteines,
U24HHV-6B has only one and U24HHV-7 has two which
are exclusively located in the transmembrane region
(and thus are not likely to form disulfide bonds). We
cannot rule out whether these differences can affect
the activity of U24 on a more precise level, or some-
how are involved in regulatory mechanisms that have
yet to be discovered.
Using the MBP-6 × His tagging system for a mem-
brane protein of interest with a generic expression strain
(i.e.: C41(DE3)), one should quickly be able to test both
cytoplasmic and periplasmic expression strategies at
high and low temperature. If there is the potential to
form a disulfide bond in the membrane protein of inter-
est, yet the oxidation state of the cysteines are unknown,
one may benefit from using the reductase deficient
SHuffle strain. Should the protein not have any disul-
fides, DsbC in SHuffle may still act as a chaperone to
induce proper folding and avoid unwanted disulfide
bonds. If co-overexpression of DsbC should fail to
induce native disulfide bonding patterns of an MBP-
fusion protein, it may be possible to correct disulfide
mispairings by an in vitro incubation of MBP-fusions
with DsbC [28], or by co-expression with the recently
characterized sulfhydryl-oxidase, Erv1p [23].
Impaired disulfide bonding may be but one of several
key obstacles in obtaining stable full-length membrane
proteins in E. coli, especially those from mammalian
sources. Polypeptide synthesis is 4-10 times faster in
prokaryotes than eukaryotes, and the apparatus by
which membrane proteins are inserted into the mem-
brane is different [29]. One approach may be to reduce
the rate of synthesis by lowering expression tempera-
ture, or to use a weaker promoter. Although MBP
appears superior to most other fusion tags in the litera-
ture, improvements in yield can result from using other
unique tags [30]. Autoexpression media [17] or novel
enzyme-based-substrate delivery media (EnBase, [31])
also represents an attractive approach for increasing
both cell mass and protein yield. Still, other advances
involve the reduction in toxicity associated with mem-
brane protein overexpression [11,25]. While these and
other trial-and-error optimization techniques may give a
modest improvement in membrane protein yield,
increasing our mechanistic understanding of prokaryotic
systems of membrane protein translation and folding is
clearly warranted. Directed evolution studies [32] and
genetic analysis of upregulation, downregulation and
mutations [33] made to house-keeping genes [34] during
membrane protein expression will undoubtedly continue
to have an impact on yields of functional membrane
proteins in E. coli.
Figure 6 Examination of cysteine-free mutant U24 expression.
The C21SC37S mutant U24 constructs were expressed: pMAL-p2x-
U24 in C41 (DE3) and pMAL-c2x-U24 in Origami 2 cells, at 18°C and
37°C. Removal of disulfide bond potential appeared to have no
effect on in vivo stability of expressed MBP-6 × His-U24, which
exhibited the same expression characteristics as wild-type; a similar
loss in mass of the degraded fusion protein is observed at the
higher temperature.
Figure 7 Mass of isolated cells expressing MBP-6 × His-U24.
Cell masses which correspond to highest yields of protein are
notably different between the cell types; although grown in rich LB
media, Origami 2 cells (pMAL-c2x-U24) are consistently ~3 × lower
in mass than C41(DE3) (pMAL-p2x-U24), which is grown in M9
minimal media. Data is based on mean ± s.d. for n = 4-5 batches of
cells isolated from 4 × 1L of culture, expressed at 18°C overnight.
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Methods
Gene construction
The gene sequence for U24 from HHV-6A was
obtained from NCBI [GenBank: Q69559]. Oligonucleo-
tide fragments that represent the full-length U24 gene
and primers were synthesized (Nucleic Acid Protein
Service Unit, University of British Columbia), replacing
codons which are rare in E. coli with ones more fre-
quently used. The codon optimized U24 gene was
assembled by overlap PCR for insertion into the
pMAL-c2x and pMAL-p2x vectors (New England Bio-
labs). For use with the pMAL-c2x and pMAL-p2x vec-
tors, the amplified gene segment included a BamHI
site at the 5’ end, followed by a sequence coding a
hexahistidine tag followed by a thrombin cleavage site
(LVPRGS), then the U24 sequence, followed by an
amber stop codon then a HindIII site at the 3’ end.
DNA fragments were purified by agarose gel electro-
phoresis and subsequently extracted using a Qiaquick
Gel Extraction Kit (Qiagen).
Cloning
The isolated gene fragments described above were incu-
bated with Taq polymerase, pCR®2.1-TOPO® vector and
dATP (all from Invitrogen) and the reaction mixtures
were used to transform competent SURE® E. coli (Strata-
gene). The E. coli were then plated on Luria Bertani (LB)
agar plates containing 50 μg/ml carbenecillin to grow
overnight at 37°C. Colonies were selected and subjected to
PCR using M13 forward and reverse primers to identify
which colonies contained the vector with the correct
inserted gene. PCR reactions for colonies which did harbor
the gene insert yielded a single band between 500-600 bp
when run by agarose gel electrophoresis. These colonies
were then grown in 5 ml of LB media with 50 μg/ml car-
benecillin overnight and their plasmids were harvested
using a QIAprep Spin Miniprep Kit (Qiagen). Isolated
plasmid DNA was sent for sequencing (Nucleic Acid Pro-
tein Service Unit, University of British Columbia) to con-
firm that the correct gene sequences were obtained.
The pCR®2.1-TOPO® vectors containing the expected
U24 gene inserts were digested by the appropriate endo-
nucleases, HindIII/BamHI. The digested fragments were
isolated as previously described, then ligated into the
corresponding pre-digested gel-purified pMAL vectors
using T4 DNA ligase (Invitrogen). SURE® E. coli were
transformed with the ligation products, the plasmids
were isolated and sequenced as before, and designated
pMAL-c2x-U24 and pMAL-p2x-U24.
Site-directed Mutagenesis
Synthetic primers were purchased (Integrated DNA
Technologies) and used according to Quikchange Site
Directed Mutagenesis Kit instructions (Stratagene).
Vectors pMAL-c2x-U24 and pMAL-p2x-U24 were used
as the starting template. To construct the C21S mutant,
the primers were 5’-CTGATGATGGACGTTAT
GTCCGGTCAGGTTTCC-3’ and 5’-GGAAACCT-
GACCGGACATAACGTCCATCATCAG-3’, which
introduces an Eam1105I-sensitive restriction site. For the
C37S mutant, the primers used were 5’-CCTTCG
TTGAATCTATTCCGCCACCG-3’and 5’-GGACTGC
GGTGGCGGAATAGATTCA-3’ and they introduced a
XmnI-sensitive restriction site. The C21S mutant plasmid
was the starting template for constructing the C21SC37S
double mutant. All plasmids were isolated and sequenced
as described above for wild-type plasmids.
Small Scale Protein Expression
The expression vector constructs pMAL-c2x-U24 and
pMAL-p2x-U24 were used to transform XL1-Blue (Stra-
tagene), BL21(DE3) (Stratagene), C41(DE3) (Lugicen),
Origami 2 (EMD Biosciences) and SHuffle (New Eng-
land Biolabs) E. coli strains. Transformed E. coli were
then plated on LB agar plates containing 50 μg/ml car-
benecillin to grow overnight at 37°C (30°C in the case of
SHuffle, as per manufacturer’s instructions). Single colo-
nies were selected and grown at these temperatures
overnight with shaking (225 r.p.m.) in 5 ml of LB, con-
taining 50 μg/ml carbenecillin. Cells were pelleted by
centrifugation, then resuspended in 100 ml of fresh
medium with antibiotics and again grown for several
hours until reaching an OD600 = 0.5-1.0. Isopropyl b-D-
1-thiogalactopyranoside (IPTG) was added at a final
concentration of 0.3 mM and the cells continued to
grow for 3 hours at the same temperature (30 or 37°C).
For growths carried out at lower temperature, the cul-
tures were cooled in a cold-water bath for 30 minutes
before addition of the IPTG, and these cultures were
then grown at 18°C for 16-20 hours. All cultures were
harvested by centrifugation at 4°C and the cells were
stored at -80°C until further use.
Large Scale Protein Expression
Small starter cultures (5 ml) were set up as described for
the small scale expression. In this case, the cultures
were grown for only three to five hours before one ml
of culture was used to inoculate 100 ml of fresh LB or
M9 minimal media containing 100 μg/ml ampicillin. M9
minimal media was supplemented with 50 μg/ml thia-
mine. These cultures were grown overnight under the
same conditions as the 5 ml cultures described in the
section above, and then harvested by centrifugation. Cell
pellets were resuspended in 4 × 1 L of fresh medium
with antibiotics and grown to an OD600 = 0.5-1.0. Cul-
tures were cooled in a cold-water bath for 30 minutes
before addition of IPTG at a final concentration of 0.3
mM, and they then continued to grow at 18°C for
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another 16-20 hours. Cultures were harvested by centri-
fugation at 4°C and the cells were stored at -80°C until
further use.
Protein Extraction and Purification
C41(DE3) cell pellets from 4 L of culture, harboring
expressed MBP-6 × His-U24, were thawed on ice and
resuspended in lysis buffer (20 mM Na+/K+ phosphate,
0.5 M NaCl, pH 7.4), adding DNase I (Roche) and
EDTA-free protease inhibitor cocktail (Sigma). Cells
were lysed by three passes through a French press, and
the lysate was centrifuged for 90 minutes at 25,000 ×
g, 4°C. The pellet was resuspended in solubilization
buffer (20 mM Na+/K+ phosphate, 0.5 M NaCl, 1%
Triton X-100, 10 mM imidazole, pH 7.4), gently stirred
for three hours at 4°C, and again centrifuged for 90
minutes at 25,000 × g, 4°C. Since substantial amount
of target protein was found in both the supernatant
and pellet of Origami 2 and SHuffle cells treated with
lysis buffer, the lysis buffer step was omitted and these
cells were resuspended directly into solubilization buf-
fer with protease inhibitor cocktail prior to being lysed
by French press. Supernatants were filtered through a
45 μm filter and loaded on a 5 ml Histrap HP column
(GE Biosciences) equilibrated with wash buffer (20
mM Na+/K+ phosphate, 0.5 M NaCl, 0.5% Triton X-
100, 10 mM imidazole, pH 7.4). The column was
washed with 30 column volumes of wash buffer. The
imidazole concentration of the wash buffer was raised
to 45 mM, and the column was further washed with
another 10 column volumes. The MBP-6 × His-U24
protein was eluted from the column in 25 ml of elu-
tion buffer (20 mM Na+/K+ phosphate, 0.5 M NaCl,
0.5% Triton X-100, 500 mM imidazole, pH 7.4) and
dialyzed overnight at 4°C against 1 L of dialysis buffer
(20 mM Na+/K+ phosphate, 62.5 mM NaCl, 0.5% Tri-
ton X-100) using a dialysis membrane with MWCO of
1000 (Spectrum Laboratories).
Dialyzed solution containing the MBP-6 × His-U24
was transferred to a 50 ml polypropylene tube, and 50
units of bovine thrombin (GE Healthcare) were added.
The digest was carried out for 48 hours at ambient
temperature.
The digest solution was filtered through a 45 μm fil-
ter and re-loaded on a 5 ml Histrap HP column equili-
brated with dialysis buffer. U24 was collected in the
flowthrough, while MBP-6 × His and any undigested
MBP-6 × His-U24 were eluted with elution buffer. To
remove the thrombin and any trace contaminants that
remained, U24 solution was loaded on a 5 ml Q-
Sepharose column (GE Biosciences) equilibrated with
dialysis buffer and pure U24 was collected in the
flowthrough. Purity was assessed by MALDI-TOF
mass spectrometry and SDS-PAGE, and protein
concentration was measured with the bicinchoninic
acid (BCA) assay (Pierce).
GluC Digests
U24 protein isolated from SHuffle E.coli was dialyzed
overnight at 4°C against 50 mM Tris·HCl, 100 mM
NaCl, pH 7.5 with a 1000 MWCO membrane. Staphylo-
coccus aureus Protease V8 (GluC, from New England
Biolabs) was dissolved in deionized water to a concen-
tration of 0.1 μg/ml then mixed with U24 (1:17 w/w), ±
20 mM DTT, and incubated for two hours at 25°C.
Reactions were quenched by addition of trichloroacetic
acid (TCA) at a final concentration of 20% (w/v). Pellets
were collected by centrifugation and washed twice with
ice-cold acetone then air-dried.
Far-UV Circular Dichroism
Protein stock solutions of U24 were precipitated by
addition of TCA, 10% (w/v), and collected by centrifuga-
tion. The protein pellets were then washed with two
additions of ice-cold acetone, vortexing and centrifuga-
tion. After acetone was removed and the sample air-
dried, the protein was reconstituted in 10 mM Tris·HCl,
10 mM NaCl, 10 mM SDS, pH 7.5, +/- 0.5 mM tris(2-
carboxyethyl)phosphine (TCEP) with an estimated final
protein concentration of 0.11 mg/ml. Protein solutions
were sonicated in a water bath until the protein was
completely dissolved, then centrifuged briefly to ensure
the removal of any particulate matter. Final protein con-
centrations of the samples were determined by BCA
assay.
Spectra were recorded with a J-810 spectropolarimeter
flushed with nitrogen gas. Using a cell with a path
length of 0.2 cm and a sample compartment that was
thermostated to 20°C, samples were scanned at a rate of
50 nm/min with a step size of 1 nm. Spectra were aver-
aged over three scans and corrected for background by
subtracting the scans of buffer without protein.
SDS-PAGE Analysis of Protein Expression
Cell pellets from 0.5 ml of culture were mixed with 50
μl 2 × Novex dye (Invitrogen) supplemented with 5%
b-mercaptoethanol and 50 μl of 50% glycerol, vortexed
and heated at 95°C for 5 minutes. BenchMark His-
tagged molecular weight markers (Invitrogen) and a 5
μl volume of each prepared sample were loaded on a
13% acrylamide gel and run by Tris-Glycine SDS-
PAGE. The initial voltage was set to 50 V for one
hour, and 100 V for the remainder of the run until the
dye front reached the bottom of the gel. Gels were
stained with a Coomassie Blue-G250 solution for 1
hour and destained with 50% methanol/10% acetic acid
or deionized water alone. For Invision staining, the
gels were treated according to manufacturer ’s
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instructions (Invitrogen). SDS-PAGE image data was
captured using a GelDoc XR imager (Biorad) and den-
sitometric analysis of protein expression was carried
out using Quantity One software, V4.6.7 (Biorad). The
contour tool and global background subtraction meth-
ods were used to select bands and calculate their rela-
tive intensities.
Purified U24 samples were mixed with equal volumes
of 2 × Novex dye that contained 5% b-mercaptoethanol
and then were heated to 95°C for 5 minutes. Samples
used in the GluC digest experiment were not heated
prior to loading on the gel, and only those that were
previously exposed to DTT contained 2.5% b-mercap-
toethanol. Gels were run, stained and destained as
before, with the exception that a Tris-Tricine gel buffer
was used in order to resolve the lower molecular weight
proteins and peptides. In these gels, Mark12 molecular
weight markers (Invitrogen) were used to estimate pro-
tein masses.
NEM modification
U24 protein isolated from C41(DE3), Origami 2 and
SHuffle E. coli strains were dialyzed overnight at 4°C
against 50 mM Tris·HCl, 100 mM NaCl, pH 7.5 with a
1000 MWCO membrane. N-ethylmaleimide (NEM) was
dissolved in the same buffer and diluted to 4 mM.
TCEP was dissolved separately in this buffer to a con-
centration of 20 mM and the pH was made slightly
basic by addition of NaOH before diluting further to a
TCEP concentration of 2 mM. Samples of U24 were
mixed 1:1 (vol:vol) with TCEP solution (+ TCEP sam-
ples) or with buffer (- TCEP samples) and incubated for
10 minutes at 37°C. These samples were then mixed 1:1
(vol:vol) with NEM solution (+ NEM samples) or buffer
(- NEM samples) and incubated in the dark for 30 min-
utes at room temperature. Reactions were quenched by
addition of trichloroacetic acid (TCA) to a final concen-
tration of 20% (w/v). Pellets were collected by centrifu-
gation and washed twice with ice-cold acetone, and then
air-dried.
MALDI-TOF Mass Spectrometry
Protein samples were dissolved in 50% acetonitrile with
0.1% trifluoroacetic acid. The matrix, sinapinic acid, was
dissolved in the same solvent to a concentration of 10
mg/ml. The matrix was spotted on the MALDI target
plate followed by the protein solution and another layer
of matrix. Volumes added were 1 μL, and the spot was
air-dried between each addition. Experiments were per-
formed on Bruker Biflex IV (Bruker Daltonics) MALDI-
TOF mass spectrometer, operating in linear ion mode
and externally calibrated with horse heart cytochrome C
and bovine ubiquitin (Sigma), giving a mass accuracy of
± 0.2%.
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